Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | REGN5459 |
Trade Name | |
Synonyms | Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459 |
Drug Descriptions |
REGN5459 is a bispecific human antibody targeting both human B-cell maturation antigen (BCMA, TNFRSF17) and CD3, which may increase antitumor immune response (Cancer Res (2023) 83 (8_Supplement): CT013). |
DrugClasses | CD3 Antibody 99 TNFRSF17 Antibody 20 |
CAS Registry Number | NA |
NCIT ID | C165656 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
REGN5459 | REGN5459 | 0 | 1 |